Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Director departure
|
|
INTEGRATED BIOPHARMA INC (INBP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| FRIEDMAN ERIC J (Director) has filed a Form 4 on INTEGRATED BIOPHARMA INC|
Txns:
| Granted 50,000 options to buy
@ $0 |
|
| 07/19/2023 |
4
| DeSantis Damon (Director) has filed a Form 4 on INTEGRATED BIOPHARMA INC|
Txns:
| Granted 50,000 options to buy
@ $0 |
|
| 07/19/2023 |
4
| Canarick Robert (Director) has filed a Form 4 on INTEGRATED BIOPHARMA INC|
Txns:
| Granted 50,000 options to buy
@ $0 |
|
| 06/01/2023 |
4
| RIVA SHEPPARD (Co-CEO) has filed a Form 4 on INTEGRATED BIOPHARMA INC|
Txns:
| Gifted 50,000 shares
@ $0.34, valued at
$17k
|
|
| 06/01/2023 |
4
| KAY CHRISTINA (Co-CEO) has filed a Form 4 on INTEGRATED BIOPHARMA INC|
Txns:
| Gifted 50,000 shares
@ $0.34, valued at
$17k
|
|
| 05/11/2023 |
8-K
| Quarterly results |
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 03/21/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 03/17/2023 |
8-K
| Entry into a Material Definitive Agreement Interactive Data |
| 02/10/2023 |
8-K
| Quarterly results |
| 02/10/2023 |
10-Q
| Quarterly Report for the period ended December 31, 2022 |
| 12/06/2022 |
8-K
| Quarterly results |
| 11/28/2022 |
8-K
| Quarterly results |
| 11/14/2022 |
8-K/A
| Quarterly results |
| 11/14/2022 |
8-K
| Quarterly results |
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 10/27/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 10/24/2022 |
8-K
| Quarterly results |
| 09/14/2022 |
8-K
| Quarterly results |
| 09/13/2022 |
10-K
| Annual Report for the period ended June 30, 2022 |
| 07/15/2022 |
8-K
| Quarterly results |
| 06/21/2022 |
4
| DeSantis Damon (Director) has filed a Form 4 on INTEGRATED BIOPHARMA INC|
Txns:
| Granted 50,000 options to buy
@ $0 |
|
| 06/21/2022 |
3
| DeSantis Damon (Director) has filed a Form 3 on INTEGRATED BIOPHARMA INC |
| 06/21/2022 |
8-K
| Quarterly results |
| 06/21/2022 |
4
| FRIEDMAN ERIC J (Director) has filed a Form 4 on INTEGRATED BIOPHARMA INC|
Txns:
| Granted 50,000 options to buy
@ $0 |
|
| 06/21/2022 |
4
| Milmoe William H. (10% Owner) has filed a Form 4 on INTEGRATED BIOPHARMA INC|
Txns:
| Granted 50,000 options to buy
@ $0 |
|
| 06/21/2022 |
4
| Canarick Robert (Director) has filed a Form 4 on INTEGRATED BIOPHARMA INC|
Txns:
| Granted 50,000 options to buy
@ $0 |
|
| 05/12/2022 |
8-K
| Quarterly results |
| 05/12/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
|
|
|